Bolt Biotherapeutics, Inc. (BOLT) Operating cash flow 2020–2025
Bolt Biotherapeutics, Inc. (BOLT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$39.9MFY2025 · since FY2020: -$47.3M → -$39.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$39.9M | +35.0% |
| FY2024 | -$61.3M | +11.8% |
| FY2023 | -$69.5M | +9.1% |
| FY2022 | -$76.5M | -34.1% |
| FY2021 | -$57.1M | -20.6% |
| FY2020 | -$47.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BOLT financial trends
BOLT RevenueBOLT Net incomeBOLT Net marginBOLT Gross profitBOLT Gross marginBOLT Operating incomeBOLT Operating marginBOLT Free cash flowBOLT Capital expendituresBOLT Return on equityBOLT Stock buybacksBOLT Dividends paidBOLT Total assetsBOLT Total liabilitiesBOLT Shareholders’ equityBOLT overview →